$NTRR Qualitative Analysis Begins on NTRR’s New Contaminants Test
Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, announced today that the qualitative testing phase of development will begin on the new advanced prototype of the company’s innovative, disposable cannabis testing strips.
Led by Dr. Richard C. Kaufman, the company’s new head of research and development in the $42 billion nutraceuticals industry, NTRR is developing a disposable system for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ) for potentially harmful contaminants.
With a new prototype now in place, the company is forging ahead with qualitative tests to improve the efficacy and efficiency of the product’s design.
“The next step is to make sure that our test for contaminants detects the proper amount of contaminants that would potentially make cannabis harmful to consume,” said NTRR CEO Sydney Jim. “This lab analysis will bring us another big step closer to getting this groundbreaking product to the patients and dispensaries who need it.”
NTRR has designed the test strips to give patients and retailers in the rapidly growing MMJ industry a closer, more detailed look at the plants they’re buying, selling and consuming. If successful, the innovative system could help NTRR capture a big share of an MMJ testing market poised for unprecedented growth as more and more states sign MMJ laws.
By providing innovative nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, announced today that the qualitative testing phase of development will begin on the new advanced prototype of the company’s innovative, disposable cannabis testing strips.
Led by Dr. Richard C. Kaufman, the company’s new head of research and development in the $42 billion nutraceuticals industry, NTRR is developing a disposable system for testing oils, butters, tinctures, resins and other concentrates derived from medical marijuana (MMJ) for potentially harmful contaminants.
With a new prototype now in place, the company is forging ahead with qualitative tests to improve the efficacy and efficiency of the product’s design.
“The next step is to make sure that our test for contaminants detects the proper amount of contaminants that would potentially make cannabis harmful to consume,” said NTRR CEO Sydney Jim. “This lab analysis will bring us another big step closer to getting this groundbreaking product to the patients and dispensaries who need it.”
NTRR has designed the test strips to give patients and retailers in the rapidly growing MMJ industry a closer, more detailed look at the plants they’re buying, selling and consuming. If successful, the innovative system could help NTRR capture a big share of an MMJ testing market poised for unprecedented growth as more and more states sign MMJ laws.
By providing innovative nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
